Joseph A. Crawley

2.1k total citations · 1 hit paper
35 papers, 1.6k citations indexed

About

Joseph A. Crawley is a scholar working on Gastroenterology, Surgery and Speech and Hearing. According to data from OpenAlex, Joseph A. Crawley has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Gastroenterology, 18 papers in Surgery and 7 papers in Speech and Hearing. Recurrent topics in Joseph A. Crawley's work include Gastroesophageal reflux and treatments (26 papers), Eosinophilic Esophagitis (15 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Joseph A. Crawley is often cited by papers focused on Gastroesophageal reflux and treatments (26 papers), Eosinophilic Esophagitis (15 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Joseph A. Crawley collaborates with scholars based in United States, United Kingdom and Brazil. Joseph A. Crawley's co-authors include Dennis A. Revicki, Ingela Wiklund, Clara Hwang, David A. Johnson, Bonnie B. Dean, Leah Kleinman, Chris L. Pashos, Colleen M. Schmitt, John B. Wong and Eric Hillson and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Medical Care.

In The Last Decade

Joseph A. Crawley

34 papers receiving 1.6k citations

Hit Papers

Reliability and validity ... 1997 2026 2006 2016 1997 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph A. Crawley United States 16 1.2k 979 310 303 244 35 1.6k
Katarina Halling Sweden 16 1.1k 0.9× 1.1k 1.1× 151 0.5× 154 0.5× 168 0.7× 39 1.8k
G. Richard Locke United States 21 2.8k 2.3× 2.8k 2.9× 212 0.7× 494 1.6× 383 1.6× 39 4.1k
S Lydeard United Kingdom 10 1.3k 1.1× 1.0k 1.0× 36 0.1× 89 0.3× 158 0.6× 11 1.7k
Filippo Catalano Italy 20 257 0.2× 311 0.3× 36 0.1× 1.0k 3.4× 690 2.8× 55 1.5k
Chih‐Kun Huang Taiwan 24 251 0.2× 1.3k 1.3× 26 0.1× 348 1.1× 458 1.9× 94 1.8k
Montse Roset Spain 13 311 0.3× 266 0.3× 15 0.0× 68 0.2× 182 0.7× 31 981
Anita Sainsbury United Kingdom 8 235 0.2× 236 0.2× 30 0.1× 51 0.2× 105 0.4× 14 744
F.G. Schellevis Netherlands 13 137 0.1× 133 0.1× 17 0.1× 118 0.4× 151 0.6× 31 748
Jennifer Talley United States 15 404 0.3× 314 0.3× 7 0.0× 145 0.5× 105 0.4× 29 908
Wladyslawa Czuber‐Dochan United Kingdom 22 252 0.2× 222 0.2× 111 0.4× 16 0.1× 63 0.3× 81 1.3k

Countries citing papers authored by Joseph A. Crawley

Since Specialization
Citations

This map shows the geographic impact of Joseph A. Crawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Crawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Crawley more than expected).

Fields of papers citing papers by Joseph A. Crawley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. Crawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Crawley. The network helps show where Joseph A. Crawley may publish in the future.

Co-authorship network of co-authors of Joseph A. Crawley

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Crawley. A scholar is included among the top collaborators of Joseph A. Crawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Crawley. Joseph A. Crawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howard, Kellee, et al.. (2014). Development Of A New Patient Reported Outcome (PRO) Measure For Community-Acquired Bacterial Pneumonia (CABP). Value in Health. 17(3). A280–A280. 2 indexed citations
2.
Coyne, Karin S., Brooke M. Currie, William C. Holmes, & Joseph A. Crawley. (2014). Assessment of a Stool Symptom Screener and Understanding the Opioid-Induced Constipation Symptom Experience. Patient. 8(4). 317–327. 13 indexed citations
4.
Powers, John H., et al.. (2014). Acute Bacterial Skin And Skin Structure Infection (Absssi): Development Of A New Patient Reported Outcome (Pro). Value in Health. 17(3). A288–A288. 1 indexed citations
5.
Crawley, Joseph A., et al.. (2013). Impact Of Opioid-Induced Constipation: A Multinational Cross-Sectional Survey Of Patients And Health Care Providers. Value in Health. 16(3). A215–A215. 1 indexed citations
6.
Johnson, David A., Joseph A. Crawley, Clara Hwang, & Kenneth N. Brown. (2010). Clinical trial: esomeprazole for moderate‐to‐severe nighttime heartburn and gastro‐oesophageal reflux disease‐related sleep disturbances. Alimentary Pharmacology & Therapeutics. 32(2). 182–190. 34 indexed citations
7.
Johnson, David A., Joseph A. Crawley, Clara Hwang, & Kurt Brown. (2009). 417 Effect of Esomeprazole On Sleep Quality in Patients with Gastroesophageal Reflux Disease (GERD)-Related Sleep Disturbances. Gastroenterology. 136(5). A–71. 1 indexed citations
8.
Gunasekaran, Thirumazhisai S., Vasundhara Tolia, Richard B. Colletti, et al.. (2009). Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study. BMC Gastroenterology. 9(1). 84–84. 8 indexed citations
10.
Vaezi, Michael F., Joel E. Richter, C. Richard Stasney, et al.. (2006). Treatment of Chronic Posterior Laryngitis With Esomeprazole. The Laryngoscope. 116(2). 254–260. 235 indexed citations
11.
Joish, Vijay N., Gary Donaldson, Gary M. Oderda, et al.. (2005). The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Current Medical Research and Opinion. 21(4). 535–543. 61 indexed citations
12.
Johnson, David A., William C. Orr, Joseph A. Crawley, et al.. (2005). Effect of Esomeprazole on Nighttime Heartburn and Sleep Quality in Patients with GERD: A Randomized, Placebo-Controlled Trial. The American Journal of Gastroenterology. 100(9). 1914–1922. 160 indexed citations
13.
Shaw, Michael J. & Joseph A. Crawley. (2003). Improving Health-Related Quality of Life in Gastro-Oesophageal Reflux Disease. Drugs. 63(21). 2307–2316. 8 indexed citations
14.
Dean, Bonnie B., Joseph A. Crawley, Colleen M. Schmitt, John B. Wong, & Joshua J. Ofman. (2003). The burden of illness of gastro‐oesophageal reflux disease: impact on work productivity. Alimentary Pharmacology & Therapeutics. 17(10). 1309–1317. 140 indexed citations
15.
Lenderking, William R., Eric Hillson, Joseph A. Crawley, et al.. (2003). The Clinical Characteristics and Impact of Laryngopharyngeal Reflux Disease on Health-Related Quality of Life. Value in Health. 6(5). 560–565. 34 indexed citations
16.
Revicki, Dennis A., et al.. (2003). Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity.. Health and Quality of Life Outcomes. 1(1). 73–73. 31 indexed citations
17.
Crawley, Joseph A., et al.. (2001). Measuring Change in Quality of Life in Response to Helicobacter pylori Eradication in Peptic Ulcer Disease. Digestive Diseases and Sciences. 46(3). 571–580. 19 indexed citations
18.
Fu, Qinggong, et al.. (1998). Utilisation and Expenditures in the Treatment of Patients with Gastro-Oesophageal Reflux Disease. Disease Management & Health Outcomes. 4(6). 325–336. 2 indexed citations
19.
Revicki, Dennis A., et al.. (1997). Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Quality of Life Research. 7(1). 75–83. 485 indexed citations breakdown →
20.
Cobb, Margaret M., et al.. (1995). LARGE-SCALE POSTMARKETING SURVEILLANCE OF HYPERTENSIVE PATIENTS TREATED WITH VERAPAMIL. American Journal of Therapeutics. 2(7). 455–461.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026